E van den Berg, G Walterbusch, L Gotzen, K D Rumpf, B Otten, H Fröhlich. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdolescentDihydroergotamine/adverse effectsDihydroergotamine/therapeutic useErgotism/chemically inducedHeparin/adverse effectsHeparin/therapeutic useHumansMaleMiddle AgedThromboembolism/prevention & control
Substances: See more » DihydroergotamineHeparin
Year: 1983 PMID: 6837130
Source DB: PubMed Journal: Vasa ISSN: 0301-1526 Impact factor: 1.961